The UK Digital Health market is projected to grow from $5.49 Bn in 2022 to $18.74 Bn by 2030, registering a CAGR of 16.6% during the forecast period of 2022-30. Higher healthcare funding by the government and growing investments by innovative start-up companies across the UK are the major drivers for the digital health market. The market is segmented by solution, by deployment & by end-use. Some of the major players include Huma, CERA CARE & Cerner Corporation.
The UK Digital Health market is projected to grow from $5.49Bn in 2022 to $18.74Bn by 2030, registering a CAGR of 16.6% during the forecast period of 2022-30. Healthcare spending in the UK as a share of GDP has raised by 10.15% in 2019 from 9.81% in 2017 as given by the World Health Organization Global Health Expenditure database and has expanded the spending nearly to 11.9% of GDP in 2021 which is much higher compared to the time before COVID -19 impacted the country’s economy.
The digital health market in the UK has observed good growth in recent years primarily due to the outbreak of COVID–19: digital solutions such as mobile health services & telehealth took off the edge in the market providing easy access to preventive solutions to a wide range of population for disease diagnosis, treatment alternatives for various chronic conditions.
In addition to NHS, other private companies are also investing a decent amount of time, assets, and technology in developing innovative digital health products & services such as telemedicine, medical device manufacturers, software, and application developers.
Market Growth Drivers
UK’s NHS is working on and has committed implementation of Electronic Health Records (EHRs) across all hospitals and communities by March 2025. NHS has also provided an NHS App which provides easy and secure access to people willing to avail of any of the NHS services online via smartphone/tablet and NHS Digital (formerly HSCIC) developed a prototype to aid healthcare staff to view patient data within NHS Digital national Spine services, in a new and innovative way.
The UK ranks top amongst the healthcare funding across Europe and also plays a leading role in research and innovations. It has built a resilient digital health start-up ecosystem doing innovation in enabling technologies, patient care, pharmaceuticals, consumer health & fitness, Family planning & sexual health, screening & diagnostics, specialized care, mental health, and others.
Market Restraints
The lack of a centralized funding model for reimbursement of digital health solutions remains one of the main barriers to the growth of the market. Though the growth of the market is substantial, concerns such as data security, lack of systematic regulation, limited reimbursement, and coordination between the various regulatory bodies are said to have an impact on how the market grows.
Key Players
The plan for digital health and social care (2022) gives a revised vision for digital health care, integrating digital health goals inside the NHS Long Term Plan, defining the duties of the newly constituted ICSs, and incorporating ambitions for digitizing the social care sector. In the UK the responsibility of digital health and care services is shared across the areas.
In Scotland, digital health care is provided by the Digital Health and Care Directorate within the Scottish government. The Local Government Digital Office (LGDO) helps accelerate its digital transformation. Digital Health and Care Wales (DHCW) in April 2021, in order to report and review required changes in digital health. Initiated work on collaboration and engagement with local partners to create systemic change, and it has its own independent board. Digital Health Care Northern Ireland (DCHNI) is in charge of managing digital health and care strategy and investment, as well as procuring digital projects to assist health and care services.
The National Health Service (NHS) is the main responsible for healthcare services in the UK. There are national funding models that are currently in place that includes local, and national funding and patient out-of-pocket payments. The NHS Long Term Plan identifies the NHS Diabetes Prevention Plan, as a locally financed initiative that includes digital health applications, as one cause of inequity that must be addressed. NHS is working to incorporate digital health solutions and encourage their adoption. However, further regulations are needed in order to fully support the growth of the digital health market in the UK.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The Digital Health Market is segmented as mentioned below:
By Solution (Revenue, USD Billion):
By Deployment (Revenue, USD Billion):
By End-use (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.